What is your approach to bladder cancer surveillance in patients who have received cyclophosphamide?
Answer from: at Academic Institution
Risk of bladder cancer following cyclophosphamide treatment can be associated with oral therapy and likely also related to cumulative dose (1). Risk of bladder cancer with intermittent IV cyclophosphamide has been reported in some observational studies, but has not been consistently reproduced (2). ...
Comments
at NYU Langone Health Arguments for intravenous as the preferred route o...
Arguments for intravenous as the preferred route o...